Zymeworks Takes Poison Pill to Block Hostile Bid
Related Posts
Law 360: Walgreens Inks $105M Deal To End Investor Suit Over Merger
Pharmacy chain Walgreens and two of its former executives have agreed to pay $105 million to end investor claims the company touted overly rosy financial projections as it sought shareholder...
Zendesk drama concludes with $10.2bn private equity acquisition
Zendesk has had a difficult time over the last several months. It has been hounded by activist investors, Jana Partners. It turned down a $17bn acquisition in February believing it was worth more....
Plot Thickens As Shareholder Advisory Firm Backs Spirit-Frontier Merger – The New York Times
After Frontier raised its offer for Spirit on Friday, the firm ISS reversed its recommendation that shareholders consider a rival bid from JetBlue. Source: Shareholder Advisory Firm Backs...
Ad group M&C Saatchi reverses decision to support takeover by Next Fifteen
Shareholders urged to vote against £310mn deal because of rival’s plunging share price Source